Oncotarget
The cover for issue 56 of Oncotarget features Figure 5, "HDAC inhibition synergizes with Hsp90 inhibition to induce apoptosis in bladder cancer.," Woodford, et al.
A side-by-side evaluation of [18F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography |
https://doi.org/10.18632/oncotarget.27184 Athira Narayan, Yu Yan, Ala Lisok, Mary Brummet, Martin G. Pomper, Wojciech G. Lesniak, Robert F. Dannals, Vanessa F. Merino, and Babak Behnam Azad |
5731-5744 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells |
https://doi.org/10.18632/oncotarget.27196 Harish Potu, Malathi Kandarpa, Luke F. Peterson, Nicholas J. Donato, and Moshe Talpaz |
5745-5754 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors |
https://doi.org/10.18632/oncotarget.27206 Amanda M. Smith, Christine R.C. Zhang, Alexandre S. Cristino, John P. Grady, J. Lynn Fink, and Andrew S. Moore |
5755-5767 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
New prognostic markers revealed by RNA-Seq transcriptome analysis after MYC silencing in a metastatic gastric cancer cell line |
https://doi.org/10.18632/oncotarget.27208 Luana de O. Lopes, Jersey H. Maués, Hygor Ferreira-Fernandes, France K. Yoshioka, Severino C. Sousa Júnior, Alcemir R. Santos, Helem F. Ribeiro, Juan A. Rey, Paulo C. Soares, Rommel R. Burbano, and Giovanny R. Pinto |
5768-5779 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Mechanisms by which PE21, an extract from the white willow Salix alba, delays chronological aging in budding yeast |
https://doi.org/10.18632/oncotarget.27209 Younes Medkour, Karamat Mohammad, Anthony Arlia-Ciommo, Veronika Svistkova, Pamela Dakik, Darya Mitrofanova, Monica Enith Lozano Rodriguez, Jennifer Anne Baratang Junio, Tarek Taifour, Paola Escudero, Fani-Fay Goltsios, Sahar Soodbakhsh, Hana Maalaoui, Éric Simard, and Vladimir I. Titorenko |
5780-5816 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center |
https://doi.org/10.18632/oncotarget.27212 Noura J. Choudhury, Mansooreh Eghtesad, Sabah Kadri, John Cursio, Lauren Ritterhouse, Jeremy Segal, Aliya Husain, and Jyoti D. Patel |
5817-5823 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity |
https://doi.org/10.18632/oncotarget.27217 Mark R. Woodford, Michael Hughes, Rebecca A. Sager, Sarah J. Backe, Alexander J. Baker-Williams, Michael S. Bratslavsky, Joseph M. Jacob, Oleg Shapiro, Michael Wong, Gennady Bratslavsky, Dimitra Bourboulia, and Mehdi Mollapour |
5824-5834 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Engineered human platelet-derived microparticles as natural vectors for targeted drug delivery |
https://doi.org/10.18632/oncotarget.27223 Jyotsna Kailashiya, Vineeta Gupta, and Debabrata Dash |
5835-5846 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
GCN5 HAT inhibition reduces human Burkitt lymphoma cell survival through reduction of MYC target gene expression and impeding BCR signaling pathways |
https://doi.org/10.18632/oncotarget.27226 Aimee T. Farria, Lisa Maria Mustachio, Zeynep H. Coban Akdemir, and Sharon Y.R. Dent |
5847-5858 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Clinicopathological correlation of immune response in human cancers |
https://doi.org/10.18632/oncotarget.27231 Yuexin Liu |
5859-5870 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Two novel ligand-independent variants of the VEGFR-1 receptor are expressed in human testis and spermatozoa, one of them with the ability to activate SRC proto-oncogene tyrosine kinases |
https://doi.org/10.18632/oncotarget.27232 Belen Alvarez-Palomo, Carme Barrot-Feixat, Helena Sarret, Jordi Requena, Montserrat Pau, Jose-Manuel Vidal-Taboada, Rafael Oliva, Josep-Lluis Ballesca, Michael J. Edel, and Jovita Mezquita-Pla |
5871-5887 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Correction: Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors |
https://doi.org/10.18632/oncotarget.27253 Ming Xu, Changhong Zhu, Xian Zhao, Cheng Chen, Hailong Zhang, Haihua Yuan, Rong Deng, Jinzhuo Dou, Yanli Wang, Jian Huang, Qin Chen, Bin Jiang, and Jianxiu Yu |
5888-5888 |
Correction | PDF | How to cite |
Correction: Epithelial-mesenchymal crosstalk induces radioresistance in HNSCC cells |
https://doi.org/10.18632/oncotarget.27254 Teresa Bernadette Steinbichler, Alshaimaa Abdelmoez, Veronika Maria Metzler, Daniel Dejaco, Herbert Riechelmann, Jozef Dudas, and Ira-Ida Skvortsova |
5889-5889 |
Correction | PDF | How to cite |
Correction: POPX2 is a novel LATS phosphatase that regulates the Hippo pathway |
https://doi.org/10.18632/oncotarget.27255 Muhammad Bakhait Rahmat, Songjing Zhang, and Cheng-Gee Koh |
5890-5891 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC